Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism
- PMID: 12853767
- DOI: 10.1097/01.ju.0000075500.11519.e8
Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism
Abstract
Purpose: We identify whether tachyphylaxis and priapism effects of sildenafil are related to regulation of phosphodiesterase-5 (PDE-5) expression.
Materials and methods: Cavernous smooth muscle cells (CSMCs) were isolated from young rats and treated with 0, 1, 10 and 25 microM sildenafil with or without 100 microM of sodium nitroprusside for 3 and 7 days. The cells were subjected to reverse transcriptase-polymerase chain reaction and Western blot analysis for PDE-5 expression. Plasmid constructs carrying PDE-5A1 and PDE-5A2 promoters were transfected into COS-7 cells, treated with 25 microM sildenafil and analyzed for promoter activities. To simulate priapism, CSMCs were cultured under anoxia or hypoxia and then analyzed for PDE-5 expression. Furthermore, rats underwent bilateral pudendal arterial ligation for 1 day to 14 weeks, and corpus cavernous tissues were subjected to reverse transcriptase-polymerase chain reaction analysis for PDE-5 expression.
Results: Up-regulation of PDE-5 was noted in CSMCs treated with 25 microM sildenafil for 7 days. PDE-5 messenger RNA and protein levels were significantly increased in the 7-day sildenafil treated cultures. Sodium nitroprusside appeared to down-regulate PDE-5 expression. Sildenafil significantly increased the activities of PDE-5A1 promoter. PDE-5 expression was significantly reduced under anoxia and hypoxia. The corpus cavernous tissue showed a gradual decrease in PDE-5 expression under ischemia.
Conclusions: Repeated treatment with sildenafil at high concentrations was needed to simulate tachyphylaxis in our cell culture system. Adequate oxygenation was important for PDE-5 expression. Thus, sicklemic patients may express PDE-5 at abnormally low levels, predisposing them at risk of stuttering priapism.
Similar articles
-
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.J Sex Med. 2006 Mar;3(2):253-64; discussion 264-5, author reply 265-6. doi: 10.1111/j.1743-6109.2006.00207.x. J Sex Med. 2006. PMID: 16490018
-
Improving erectile function by silencing phosphodiesterase-5.J Urol. 2005 Sep;174(3):1142-8. doi: 10.1097/01.ju.0000168615.37949.45. J Urol. 2005. PMID: 16094082
-
Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.BJU Int. 2007 Mar;99(3):612-8. doi: 10.1111/j.1464-410X.2006.06618.x. Epub 2006 Dec 6. BJU Int. 2007. PMID: 17176295
-
Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.J Sex Med. 2004 Nov;1(3):322-36. doi: 10.1111/j.1743-6109.04047.x. J Sex Med. 2004. PMID: 16422964 Review.
-
Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.Mol Pharmacol. 2003 Jun;63(6):1209-11. doi: 10.1124/mol.63.6.1209. Mol Pharmacol. 2003. PMID: 12761329 Review. No abstract available.
Cited by
-
The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence.J Endocrinol Invest. 2019 Jun;42(6):715-725. doi: 10.1007/s40618-018-0977-y. Epub 2018 Nov 10. J Endocrinol Invest. 2019. PMID: 30415310 Free PMC article. Clinical Trial.
-
Molecular Yin and Yang of erectile function and dysfunction.Asian J Androl. 2008 May;10(3):433-40. doi: 10.1111/j.1745-7262.2008.00396.x. Asian J Androl. 2008. PMID: 18385905 Free PMC article. Review.
-
Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.J Sex Med. 2019 Dec;16(12):1988-1999. doi: 10.1016/j.jsxm.2019.09.012. Epub 2019 Oct 24. J Sex Med. 2019. PMID: 31668730 Free PMC article.
-
Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update.Asian J Androl. 2016 Sep-Oct;18(5):723-31. doi: 10.4103/1008-682X.167721. Asian J Androl. 2016. PMID: 26620458 Free PMC article. Review.
-
Measurement of PDE5 concentration in human serum: proof-of-concept and validation of methodology in control and prostate cancer patients.J Endocrinol Invest. 2025 Jan;48(1):153-160. doi: 10.1007/s40618-024-02428-w. Epub 2024 Oct 1. J Endocrinol Invest. 2025. PMID: 39352630 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources